Immunohistochemistry and alternative FISH testing in breast cancer with HER2 equivocal amplification
Literature
Read More
NeoGenomics Reports Revenue of $67.8 Million on 18.7% Clinical Volume Growth and $10.5 Million of Adjusted EBITDA in the Fourth Quarter of 2017
Press Release
Read More
Correlation of MET gene amplification and TP53 mutation with PD-L1 expression in non-small cell lung cancer
Literature
Read More
NeoGenomics Schedules its Fourth Quarter and Fiscal Year 2017 Earnings Release for February 21, 2018
Press Release
Read More
Prostatectomy-based validation of combined urine and plasma test for predicting high grade prostate cancer
Literature
Read More